Netupitant/palonosetron in the management of concurrent chemoradiotherapy-induced nausea and vomiting in head and neck cancer patient

9 Sept 2024Oncology

Reema Subramanian

This content is sponsored. It is intended for healthcare professionals only.

// ONCOLOGY Last updated: | In: Article Keywords Prof Victor LEE Department Chairperson and Clinical Associate Professor The University of Hong Kong Treatment-induced nausea and vomiting remains a challenge for head and neck cancer (HNC) patients Nasopharyngeal cancer (NPC) is endemic in Southern Ch

Netupitant/palonosetron in the management of concurrent chemoradiotherapy-induced nausea and vomiting in head and neck cancer patient

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.